MENU
DVA
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

DVA stock forecast, quote, news & analysis

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
DVA
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for DVA with price predictions
Oct 08, 2026

Momentum Indicator for DVA turns positive, indicating new upward trend

DVA saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 60 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 62 cases where DVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.

The Moving Average Convergence Divergence (MACD) for DVA just turned positive on October 05, 2026. Looking at past instances where DVA's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.

Following a +0.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in 241 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

DVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 143 of 237 cases where DVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. DVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (91.743) is normal, around the industry mean (208.195). P/E Ratio (15.091) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (0.436) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (2.688).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.84B. The market cap for tickers in the group ranges from 20.9K to 93.66B. HCA holds the highest valuation in this group at 93.66B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was 1%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 25%. OPCH experienced the highest price growth at 38%, while NIVF experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was 33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 45
Price Growth Rating: 55
SMR Rating: 66
Profit Risk Rating: 87
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
DVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of integrated dialysis services for patients suffering from chronic kidney failure

Industry HospitalNursingManagement

Industry
Medical Or Nursing Services
Address
2000 16th Street
Phone
+1 720 631-2100
Employees
78000
Web
https://www.davita.com
Momentum Indicator for DVA turns positive, indicating new upward trend